Immunovant, Inc. (IMVT) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. Welcome to the Roy Vance Second Quarter 2025 earnings call. At this time, all participants are in a listen-only mode. After this speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's conference is being recorded. I will now hand the conference over to your first speaker, Stephanie Lee. You may begin. Good morning, and thanks for joining today's call to review Roygan's financial results for the second quarter ended September 30th, 2025. I'm Stephanie Lee with Roygan. Presenting today, we have Matt Klein, CEO of Roygan. For those dialing in via conference call, you can find the slides being presented today, as well as the press release announcing these updates on our IR website at www.investor.roygan.com. We'll also be providing the current slide numbers as we present to help you follow along. I'd like to remind you that we will be making certain forward-looking statements during today's presentation. We strongly encourage you to review the information that we filed with the FTC for more information regarding these forward-looking statements and related risks and uncertainty. And with that, I'll turn it over to Matt. Thank you, Steph, and good morning, everybody, and thank you for listening. I appreciate all your dialing in. say uh not at all a quiet quarter for us and that we put out uh both the graves data and obviously the phase three day for for brett chitin and dm sort of a tremendous moment of transformation for the business but a relatively quiet earnings call as we're looking forward to getting everybody together uh in december for a more f...